Enhanced expression of BMI1 was detected in a variety of cancer entities, including hematological malignancies such as CML and AML, and serves both as a biomarker and prognostic marker [86]. The gene discussed is BMI1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.